Jaguar Health plans Neonorm Dog launch via Amazon, Chewy

Jaguar Health unveiled Neonorm Dog, extending its Neonorm franchise into the companion animal market to broaden revenue opportunities.

Planned distribution via Amazon and Chewy targets scaled e-commerce reach, accelerating brand awareness beyond existing foal and calf products.

Survey data signaled strong adoption potential: 90% of 33 veterinary oncologists saw clinical relevance; 94% of 18 dog owners indicated purchase intent.

Positioning centers on non-antibiotic digestive support, aiming to differentiate in a crowded pet GI category and support repeat, at-home use.